This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 1 of 1 for:    11-C-0100
Previous Study | Return to List | Next Study

Gemcitabine and CT-011 for Resected Pancreatic Cancer

This study has been terminated.
(Drug supply issues)
Sponsor:
Information provided by (Responsible Party):
Samir N. Khleif, Augusta University
ClinicalTrials.gov Identifier:
NCT01313416
First received: March 10, 2011
Last updated: September 15, 2017
Last verified: September 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2017
  Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)